Major clinical guidelines support Urea Breath Testing (UBT) for the detection of H. pylori infection:
· For Initial Diagnosis: “The UBT … tests provide reliable means of identifying active H. pylori infection before antibiotic therapy.”1
· For Post-treatment Follow-up: “UBT is the most reliable nonendoscopic test to document eradication of H. pylori infection.”1
· As a preferred modality: “A positive [H. pylori blood antibody] test is no better than a coin toss in predicting the presence of active infection.”1
The BreathID® Breath Test System from Exalenz Bioscience offers compelling advantages for your practice:
Reimbursement is straightforward using established CPT codes (83013 & 83014).
Fast
· 10 minutes from start to results
· Enables on-the-spot testing
(patients presenting with symptoms)
· Test & treat in a single visit
Accurate
· 100% Sensitivity, 99.2% Specificity2
· ~150 exhalations included in analysis
· Validated in multiple studies published in peer-reviewed journals
· Used in numerous pharmaceutical and academic clinical trials
Easy
· CLIA non-regulated (no CLIA license required)
· Any trained staff member can operate the system
· Simple, 1-button operation
· Easy for patient – patient breathes normally
With the BreathID® System in your office, you can advance your care of patients who present with GI symptoms, abdominal pain, dyspepsia and ulcers:
· Get accurate results
· Advance patient diagnosis – for initial diagnosis and confirmation of eradication
· Confidently establish treatment plans
· Streamline patient management
1. Chey W, et al. American college of gastroenterology guideline on the management of helicobacter pylori infection. Am J Gastro 2007; 102: 1808-25.
2. Data on file, Exalenz Bioscience, Ltd.
